Skip to Content

The cloud-computing revolution has at last come for life sciences, thanks to Veeva’s industry-targeted offerings that help companies manage data-intensive processes such as clinical trials, regulatory submissions, and sales operations. The company, which counts leading biopharma companies like Pfizer, GSK, and Moderna as customers, has a market cap of $41 billion and has grown sales at a robust 26% annual rate over the past three years.

Courtesy of Veeva Systems
Lists ranking Veeva Systems
Future 50 - 2020Explore this year's ranking of the 50 companies wi...READ MOREview in list
100 Fastest-Growing Companies - 2020Collectively, the ranked companies produced a thre...READ MOREview in list
Latest news for Veeva Systems